Corporate calendar for NeoGenomics, Inc. (NEO): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company operates through two distinct divisions: Clinical Services and Pharma Services. Its comprehensive offerings cater to a diverse clientele, including hospitals, reference laboratories, pathologists, oncologists, clinicians, pharmaceutical companies, and researchers.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-16 | ||
| 2026-09-16 | $-0.03 | $1M |
| 2026-09-16 | $352M | |
| 2026-09-16 | $5M | |
| 2026-09-16 | ||
| 2026-09-16 | $-55.20 |
Dividend History
| Date | Amount | Yield |
|---|---|---|
| 2020-12-17 | $0.4000 | 8.17% |
Stock Splits
| Date | Ratio |
|---|---|
| 2003-04-16 | 1:100 |
| 2000-11-17 | 4:1 |
Price
| Price | $19.59 |
| Market Cap | $503M |
| Exchange | NASDAQ |
| Country | US |
Analyst Consensus
| Strong Buy | 1 |
| Buy | 22 |
| Hold | 5 |
| Sell | 1 |
| Strong Sell | 0 |
| Total analysts | 29 |
| Avg rating (1-5) | 0.79 |
Related companies: ACRS · ARCT · HUMA · MDXH · QTRX · SGMT · SMTI
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of NEO: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks